Hologic Statistics
Total Valuation
Hologic has a market cap or net worth of $13.11 billion. The enterprise value is $14.01 billion.
| Market Cap | 13.11B |
| Enterprise Value | 14.01B |
Important Dates
The last earnings date was Thursday, May 1, 2025, after market close.
| Earnings Date | May 1, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Hologic has 222.85 million shares outstanding. The number of shares has decreased by -4.36% in one year.
| Current Share Class | 222.85M |
| Shares Outstanding | 222.85M |
| Shares Change (YoY) | -4.36% |
| Shares Change (QoQ) | -2.73% |
| Owned by Insiders (%) | 0.83% |
| Owned by Institutions (%) | 104.06% |
| Float | 220.71M |
Valuation Ratios
The trailing PE ratio is 24.60 and the forward PE ratio is 13.72. Hologic's PEG ratio is 1.61.
| PE Ratio | 24.60 |
| Forward PE | 13.72 |
| PS Ratio | 3.38 |
| Forward PS | 3.08 |
| PB Ratio | 2.84 |
| P/TBV Ratio | 40.84 |
| P/FCF Ratio | 13.16 |
| P/OCF Ratio | 11.58 |
| PEG Ratio | 1.61 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.19, with an EV/FCF ratio of 14.07.
| EV / Earnings | 25.17 |
| EV / Sales | 3.48 |
| EV / EBITDA | 11.19 |
| EV / EBIT | 14.67 |
| EV / FCF | 14.07 |
Financial Position
The company has a current ratio of 3.24, with a Debt / Equity ratio of 0.55.
| Current Ratio | 3.24 |
| Quick Ratio | 2.29 |
| Debt / Equity | 0.55 |
| Debt / EBITDA | 1.96 |
| Debt / FCF | 2.54 |
| Interest Coverage | 7.74 |
Financial Efficiency
Return on equity (ROE) is 11.77% and return on invested capital (ROIC) is 8.20%.
| Return on Equity (ROE) | 11.77% |
| Return on Assets (ROA) | 6.92% |
| Return on Invested Capital (ROIC) | 8.20% |
| Return on Capital Employed (ROCE) | 12.64% |
| Revenue Per Employee | $576,037 |
| Profits Per Employee | $79,642 |
| Employee Count | 6,990 |
| Asset Turnover | 0.47 |
| Inventory Turnover | 2.30 |
Taxes
In the past 12 months, Hologic has paid $124.60 million in taxes.
| Income Tax | 124.60M |
| Effective Tax Rate | 18.29% |
Stock Price Statistics
The stock price has decreased by -21.73% in the last 52 weeks. The beta is 0.55, so Hologic's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | -21.73% |
| 50-Day Moving Average | 59.61 |
| 200-Day Moving Average | 72.36 |
| Relative Strength Index (RSI) | 54.13 |
| Average Volume (20 Days) | 3,738,170 |
Short Selling Information
The latest short interest is 5.35 million, so 2.40% of the outstanding shares have been sold short.
| Short Interest | 5.35M |
| Short Previous Month | 6.71M |
| Short % of Shares Out | 2.40% |
| Short % of Float | 2.43% |
| Short Ratio (days to cover) | 1.59 |
Income Statement
In the last 12 months, Hologic had revenue of $4.03 billion and earned $556.70 million in profits. Earnings per share was $2.39.
| Revenue | 4.03B |
| Gross Profit | 2.46B |
| Operating Income | 955.20M |
| Pretax Income | 789.10M |
| Net Income | 556.70M |
| EBITDA | 1.25B |
| EBIT | 955.20M |
| Earnings Per Share (EPS) | $2.39 |
Balance Sheet
The company has $1.63 billion in cash and $2.53 billion in debt, giving a net cash position of -$905.30 million or -$4.06 per share.
| Cash & Cash Equivalents | 1.63B |
| Total Debt | 2.53B |
| Net Cash | -905.30M |
| Net Cash Per Share | -$4.06 |
| Equity (Book Value) | 4.62B |
| Book Value Per Share | 20.73 |
| Working Capital | 2.22B |
Cash Flow
In the last 12 months, operating cash flow was $1.13 billion and capital expenditures -$136.00 million, giving a free cash flow of $995.50 million.
| Operating Cash Flow | 1.13B |
| Capital Expenditures | -136.00M |
| Free Cash Flow | 995.50M |
| FCF Per Share | $4.47 |
Margins
Gross margin is 61.01%, with operating and profit margins of 23.72% and 13.83%.
| Gross Margin | 61.01% |
| Operating Margin | 23.72% |
| Pretax Margin | 16.92% |
| Profit Margin | 13.83% |
| EBITDA Margin | 31.10% |
| EBIT Margin | 23.72% |
| FCF Margin | 24.72% |
Dividends & Yields
Hologic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.36% |
| Shareholder Yield | 4.36% |
| Earnings Yield | 4.25% |
| FCF Yield | 7.60% |
Analyst Forecast
The average price target for Hologic is $79.00, which is 34.33% higher than the current price. The consensus rating is "Buy".
| Price Target | $79.00 |
| Price Target Difference | 34.33% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | 5.40% |
| EPS Growth Forecast (5Y) | 10.41% |
Stock Splits
The last stock split was on April 3, 2008. It was a forward split with a ratio of 2:1.
| Last Split Date | Apr 3, 2008 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Hologic has an Altman Z-Score of 4.29 and a Piotroski F-Score of 7.
| Altman Z-Score | 4.29 |
| Piotroski F-Score | 7 |